Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here


August’s top news stories

Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN)…